Response to Marlicz et al
暂无分享,去创建一个
R. Enns | C. Andrews | P. F. Brian E. Lacy MD | Facg Colin W. Howden MD | C. Paul Moayyedi MB | Facg Nimish Vakil MD
[1] K. Skonieczna-Żydecka,et al. Test and Treat H. Pylori Eradication in Dyspepsia—“A Bridge too Far” in the Concensus? , 2018, The American Journal of Gastroenterology.
[2] L. Peirson,et al. Risk of Advanced Adenoma, Colorectal Cancer, and Colorectal Cancer Mortality in People With Low-Risk Adenomas at Baseline Colonoscopy: A Systematic Review and Meta-Analysis , 2017, The American Journal of Gastroenterology.
[3] P. Moayyedi,et al. ACG and CAG Clinical Guideline: Management of Dyspepsia. , 2017, The American journal of gastroenterology.
[4] John J Kim,et al. Helicobacter pylori eradication therapy for functional dyspepsia: Systematic review and meta-analysis. , 2016, World journal of gastroenterology.
[5] R. Hunt,et al. Helicobacter pylori eradication therapy to prevent gastric cancer in healthy asymptomatic infected individuals: systematic review and meta-analysis of randomised controlled trials , 2014, BMJ : British Medical Journal.
[6] J. Mason,et al. Effect of population screening and treatment for Helicobacter pylori on dyspepsia and quality of life in the community: a randomised controlled trial , 2000, The Lancet.